The ATX peptide vaccine's beneficial effects on DR likely depend on intraocular LPA concentrations, meaning that measuring LPA is required to prove the effects of VA in type 2 diabetes. This evidence concerns the gene ENPP2 and type 2 diabetes mellitus.